The Food and Drug Administration Friday issued recommendations for health care providers to reduce the risk of adverse events associated with surgical staplers and staples for internal use. Among other recommendations, FDA recommends providers carefully follow the stapler manufacturer’s instructions for use, have a range of staple sizes available and select the appropriate size cartridge for the tissue. Since 2011, the agency has received more than 41,000 medical device reports for surgical staplers and staples for internal use, including 366 deaths. FDA plans this year to issue draft guidance to manufacturers on information to include in their product labeling and to hold a public meeting on whether to reclassify the staplers as Class II devices, which would allow the agency to establish mandatory special controls to mitigate known risks.

Related News Articles

Perspective
Today marks three full years that the COVID-19 public health emergency has existed in the United States. That means for 1,097 days, hospitals and health care…
Headline
AHA today submitted comments on how the Agency for Healthcare Research and Quality can best support the field in advancing patient safety through an…
Headline
The National Quality Forum’s Measure Applications Partnership is accepting public comment through Dec. 7 at 6 p.m. ET on 52 performance measures the…
Headline
Health and Human Services Secretary Xavier Becerra and leaders from the Agency for Healthcare Research and Quality, Centers for Disease Control and Prevention…
Headline
The Department of Health and Human Services will host a Nov. 14 listening session with health care systems and other stakeholders on its plan to create a…
Chairperson's File
Hospital and health system teams have persevered to ensure patients receive safe, quality care during the past nearly three years of the COVID-19 pandemic.…